Femmflo
What does your company do?
Femmflo is South Africa’s first AI-powered hormone and mental health platform offering both in-lab and at-home testing.
Some Background :
70% of women go undiagnosed for hormonal issues, often waiting seven years and spending up to $18,000 to get answers. 30% report symptoms but lack access to affordable, personalised tools.
Femmflo uses AI to offer smart symptom tracking, lab guidance, and tailored care plans. Our AI MVP is live, trained on real lab and user data, and we’re now entering beta launch. We’ve partnered with Epicentre and Mzanzi Medicine, completed a 10-user in-lab pilot, collected 200+ survey responses, and onboarded 50 beta users.
We are raising $200K pre-seed to fund the build and launch of our full app MVP, scale our AI engine, and go live with employer and lab partners.
This raise will:
Finalise our app MVP (Q2 2025)
Launch with Discovery, Vitality, Old Mutual
Run marketing pilots in Kenya, Nigeria, and the UAE
This round supports a 14-month runway. Projected revenue grows from $839K (2027) to $12.8M (2030). An optional $100K raise may follow to support international scale.
What is your biggest success?
My biggest success has been building Femmflo from a deeply personal health journey into South Africa’s first AI-powered hormone and mental health platform. After developing endometriosis as a result of the trauma of being sexually assaulted, I spent over a decade navigating misdiagnosis and medical dismissal. I turned that lived experience into action. Within a year, we bootstrapped $13,000, launched our AI MVP, partnered with Epicentre and Mzanzi Medicine, grew to 2,000 organic social media users, and onboarded 50 beta testers. Our AI is already live and training on real African lab and user data, positioning us at the forefront of a $580M market opportunity across South Africa, Nigeria, Kenya, and the UAE. Turning my personal healing journey into a platform that empowers thousands of women to find answers faster using their voice is my proudest achievement.
https://docsend.com/v/pff8v/aidemovideo (demo video)
What has been your biggest hurdle?
Launching a femtech platform in a market where only 3% of women-led startups secure venture funding has been a major challenge. Despite this, we bootstrapped Femmflo from idea to a live AI MVP, onboarding 2,000+ organic social media users, partnering with Epicentre Health Research and Mzanzi Medicine, and completing a 200+ survey validation. Our AI is trained on real African lab and user data, and we are entering a 50-woman beta launch. As a small team, we have achieved early traction and real-world validation without external funding. We have now entered our first external raise to complete our app MVP and scale across South Africa, Kenya, Nigeria, and the UAE. Another major challenge was overcoming personal trauma to lead publicly as a founder, turning a painful health journey into a source of innovation. Through persistence, strategic partnerships, and resilience, we have built strong early traction, completed clinical pilots, and positioned ourselves to scale across emerging markets.
